| The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. | |
| | |
MedLine Citation:
|
PMID: 18990174 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To test the hypothesis that patients with bladder cancer who had evidence of lymphovascular invasion (LVI) in their transurethral resection of bladder tumour (TURBT) and radical cystectomy (RC) specimens would have a worse prognosis and higher likelihood of clinical understaging, and to assess the effect of LVI discovered at RC on subsequent disease-related mortality, as the prognostic significance of LVI in TURBT or RC specimens of patients treated for urothelial carcinoma of the bladder is not completely established. PATIENTS AND METHODS: We retrospectively reviewed the records of 163 patients with urothelial carcinoma of the bladder seen at our institution, and who had TURBT (69) or RC (94) between 1995 and 2005. We compared patients with LVI on TURBT and/or RC specimens to a group of controls who did not have LVI on TURBT (34) or RC (32). RESULTS: Patients with LVI present in their TURBT specimen had a shorter disease-specific survival than those without LVI, with a 5-year survival of 33.6% vs 62.9% (log-rank test P = 0.027; hazard ratio 2.21). LVI at TURBT varied with clinical stage (P = 0.049). Patients with LVI and who were clinical stage I or II had lower survival than those without LVI (P = 0.049; hazard ratio 2.68). LVI did not affect survival among those with clinical stage III or IV (P = 0.29). There was a trend for patients with LVI at TURBT to be clinically understaged compared to those without LVI (75% vs 46%) but the difference was not significant (P = 0.086). Patients with LVI detected in their RC specimen were significantly more likely to have cancer recurrence than were those with no evidence of LVI (48% vs 19%, P = 0.006). For the RC group there was also a significant difference in survival distribution between patients with evidence of LVI vs those without (5-year survival 45.5% vs 78.4%, P = 0.017). Those with LVI were significantly more likely to die from the disease than those without LVI (P = 0.017; hazard ratio 2.92). CONCLUSIONS: Our findings suggest that LVI is a histological feature that might be associated with a poorer prognosis in patients with urothelial carcinoma of the bladder. The presence of LVI in TURBT specimens predicts shorter survival for patients with stage I or II disease. The presence of LVI in RC specimens predicts recurrence of disease and shorter survival. Further studies are needed to determine whether this group of patients would benefit from early RC and/or perioperative chemotherapy to improve clinical outcomes. |
| | |
Authors:
|
Necole M Streeper; Christopher M Simons; Badrinath R Konety; DeSirae M Muirhead; Richard D Williams; Michael A O'Donnell; Fadi N Joudi |
Related Documents
:
|
17076944 - Urological surveillance and management of patients with neurogenic bladder: results of ... 10601404 - Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is th... 943804 - Duplication of the urethra. 2474194 - Abdominal ultrasound versus intravenous urography in the evaluation of infravesically o... 66574 - Complement activation in migraine. 6182974 - Intracranial metastases in small cell carcinoma of the lung: correlation of clinical an... |
Publication Detail:
|
Type: Journal Article Date: 2008-10-06 |
Journal Detail:
|
Title: BJU international Volume: 103 ISSN: 1464-410X ISO Abbreviation: BJU Int. Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-02-03 Completed Date: 2009-03-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100886721 Medline TA: BJU Int Country: England |
Other Details:
|
Languages: eng Pagination: 475-9 Citation Subset: IM |
Affiliation:
|
Department of Urology, University of Iowa, Iowa City, IA 52242-1089, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Cystectomy / methods* Female Humans Lymphatic Metastasis Male Middle Aged Neoplasm Invasiveness Neoplasm Staging Prognosis Regression Analysis Retrospective Studies Risk Factors Survival Analysis Treatment Outcome Urinary Bladder Neoplasms / mortality, pathology*, surgery Vascular Neoplasms / mortality, pathology* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 yea...
Next Document: Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a r...